Gene · 3140
Papers1,845
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,845
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| E-cigarette use-associated lung injury (EVALI). | Pneumologie | 2024 | 37857323 | PubTator, text mining | PubMed |
| MR1 antigen presentation to MAIT cells and other MR1-restricted T cells. | Nat Rev Immunol | 2024 | 37773272 | PubTator, text mining | PubMed |
| T Cell Repertoire Homogeneity and Blood-Gut Overlap in Patients With Inflammatory Bowel Disease. | Cell Mol Gastroenterol Hepatol | 2024 | 37714427 | PubTator, text mining | PubMed |
| Natural killer cells and innate lymphoid cells but not NKT cells are mature in their cytokine production at birth. | Clin Exp Immunol | 2024 | 37556759 | PubTator, text mining | PubMed |
| T cell and bacterial microbiota interaction at intestinal and skin epithelial interfaces. | Discov Immunol | 2023 | 38567051 | PubTator, text mining | PubMed |
| A comprehensive battery of flow cytometric immunoassays for the in vitro testing of chemical effects in human blood cells. | Front Immunol | 2023 | 38229911 | PubTator, text mining | PubMed |
| Acceptance of and Adherence to a Four-Dose RTS,S/AS01 Schedule: Findings from a Longitudinal Qualitative Evaluation Study for the Malaria Vaccine Implementation Programme. | Vaccines (Basel) | 2023 | 38140205 | PubTator, text mining | PubMed |
| Recyclability of Post-Consumer Polystyrene at Pilot Scale: Comparison of Mechanical and Solvent-Based Recycling Approaches. | Polymers (Basel) | 2023 | 38139965 | PubTator, text mining | PubMed |
| A Rare Variant in MDH2 (rs111879470) Is Associated with Predisposition to Recurrent Breast Cancer in an Extended High-Risk Pedigree. | Cancers (Basel) | 2023 | 38136396 | PubTator, text mining | PubMed |
| Natural Killer T Cell Diversity and Immunotherapy. | Cancers (Basel) | 2023 | 38136283 | PubTator, text mining | PubMed |
| Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guérin vaccination. | Nat Commun | 2023 | 38129388 | PubTator, text mining | PubMed |
| Optimal timing of measles vaccination in high-risk areas: Insights from MR-1 administration and subsequent dosing efficacy. | J Prev Med Hyg | 2023 | 38125985 | PubTator, text mining | PubMed |
| Unraveling the Phenotypic States of Human innate-like T Cells: Comparative Insights with Conventional T Cells and Mouse Models. | bioRxiv | 2023 | 38105962 | PubTator, text mining | PubMed |
| Oblivious network intrusion detection systems. | Sci Rep | 2023 | 38102146 | PubTator, text mining | PubMed |
| DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies. | Front Immunol | 2023 | 38090585 | PubTator, text mining | PubMed |
| Single-cell analysis for identification of T-cell clonotypes associated with IgG4 production of autoimmune pancreatitis. | Gastroenterol Rep (Oxf) | 2023 | 38077694 | PubTator, text mining | PubMed |
| Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success. | Cancers (Basel) | 2023 | 38067396 | PubTator, text mining | PubMed |
| Innate TCRβ-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentials. | Sci Adv | 2023 | 38055824 | PubTator, text mining | PubMed |
| The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications. | Front Immunol | 2023 | 38053999 | PubTator, text mining | PubMed |
| Recurrence prediction of lung adenocarcinoma using an immune gene expression and clinical data trained and validated support vector machine classifier. | Transl Lung Cancer Res | 2023 | 38025809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3140/papers?page=9